Skip to main content

Bowel and digestive system

Appendiceal cancer (cancer of the appendix): types, symptoms, diagnosis and treatment

Cancer of the appendix is rare and is often discovered only after the appendix has been removed for suspected appendicitis. The main types described in UK sources are neuroendocrine tumours and mucinous tumours that can lead to pseudomyxoma peritonei. This guide explains the types, symptoms, tests and treatment, and where UK information is limited.

Last checked: 2026-10-10

Key facts

At a glance.

  • Uncommon and often found by chance

    Neuroendocrine Cancer UK says appendix tumours are uncommon and are usually only discovered following treatment, for example when tissue is examined after an appendicectomy.

  • Symptoms can mimic appendicitis

    Neuroendocrine Cancer UK says symptoms, if they occur, tend to be the same as for suspected appendicitis.

  • Different types behave differently

    Neuroendocrine tumours of the appendix are often caught early and cured by surgery, while mucinous tumours can spread within the abdomen as pseudomyxoma peritonei, according to UK charity pages.

  • Small tumours may need no more treatment

    Neuroendocrine Cancer UK says appendiceal tumours under 1cm that are completely removed often need no further treatment or follow-up.

  • Specialist team review

    There is consensus agreement that all people with neuroendocrine neoplasms should be reviewed by a specialist multidisciplinary team (MDT), according to Neuroendocrine Cancer UK.

What appendiceal cancer is

The appendix is a small thin tube attached to the large bowel on the lower right side of the abdomen. Neuroendocrine Cancer UK describes it as being near the junction where the large and small bowel meet, and notes it has no clearly identified function in humans. Cancer Research UK says the role of the appendix is unclear.

Appendiceal cancer is a group of rare tumours that start in the appendix. The two groups described most clearly in UK patient information are neuroendocrine neoplasms (NENs), which start in neuroendocrine cells, and mucinous tumours, such as a low grade appendiceal mucinous neoplasm (LAMN), which can cause pseudomyxoma peritonei (PMP).

Neuroendocrine Cancer UK says appendix NENs are uncommon but make up the majority of appendiceal neoplasms. It explains that NETs (neuroendocrine tumours) are well-differentiated and tend to have a slow to moderate growth pattern, while NECs (neuroendocrine carcinomas) are poorly differentiated and tend to grow rapidly. The sources read for this page do not give national incidence figures for appendiceal cancer, so none are quoted.

The main types

Neuroendocrine tumours of the appendix are usually small. Neuroendocrine Cancer UK says most are located at the tip of the appendix and are diagnosed at an early stage, meaning curative surgery can be performed, while a small proportion are at the base of the appendix and may need further and longer-term interventions.

Mucinous tumours behave differently. Cancer Research UK explains that pseudomyxoma peritonei usually begins in the appendix as a small growth called a polyp, known as a LAMN, which is different from the polyps that cause bowel cancer. The cells make mucus, which collects in the abdomen as a jelly-like fluid called mucin. Cancer Research UK says it usually grows slowly and spreads inside the abdomen along the peritoneum, rather than through the blood or lymphatic system to other parts of the body.

Macmillan says PMP usually starts in the appendix but can start in another part of the bowel, the bladder or the ovaries. Because it develops very slowly, Cancer Research UK says it can be years before there are symptoms, and it has usually spread beyond the appendix before diagnosis. Pseudomyxoma peritonei has its own guide on this site; this page focuses on the appendix as the starting point.

Symptoms and when to get help

Many appendix tumours cause no symptoms and are found incidentally. When symptoms occur, Neuroendocrine Cancer UK says they may be the same as for suspected appendicitis and are rarely associated with a neuroendocrine cancer syndrome.

The NHS describes appendicitis as pain that usually starts around the belly button and after a few hours moves to the lower right side of the abdomen and gets worse, sometimes with feeling or being sick, loss of appetite, a high temperature and constipation or diarrhoea. It says appendicitis needs urgent treatment in hospital.

For mucinous tumours, Macmillan lists a gradual increase in waist size, a hernia, loss of appetite, unexplained weight gain, tummy pain, pelvic pain and changes in bowel habit among symptoms of PMP. Cancer Research UK adds swelling and bloating, a feeling of fullness and, in women, that PMP can sometimes be confused with ovarian cancer.

  • The NHS says to ask for an urgent GP appointment or get help from NHS 111 if you have tummy pain that is gradually getting worse, does not go away, or moves to the lower right side.

  • The NHS says to call 999 or go to A&E for severe tummy pain, or confusion, blotchy or paler than usual skin or difficulty breathing, which could be signs of sepsis.

  • See a GP for a gradually increasing waist size, a new hernia or persistent bloating and unexplained weight change, even though these have many other causes.

How it is diagnosed

The commonest route is incidental. Neuroendocrine Cancer UK says appendix NENs are usually discovered following treatment, for example a histology review following appendicectomy, meaning the removed appendix is examined under the microscope. Cancer Research UK says doctors sometimes find PMP by accident during treatment for other conditions.

Once a tumour is identified, further tests depend on the type. For neuroendocrine tumours, Neuroendocrine Cancer UK lists blood and urine tests (including full blood count, liver and kidney function, tumour markers such as CEA, chromogranin A and urinary or serum 5-HIAA), CT or MRI scans, nuclear medicine scans such as octreotide SPECT or gallium-dotatate PET/CT, endoscopy including colonoscopy, and specialised pathology tests. Grading, which describes how fast the tumour is growing and may be referred to as Ki67 or mitotic index in clinic letters, runs from grade 1 (slow growing) to grade 3 (more aggressive).

For PMP, Cancer Research UK lists ultrasound, CT and MRI scans, and says doctors can sometimes only diagnose it properly after an operation to look into the abdomen. Macmillan adds that a biopsy may be taken during keyhole surgery (laparoscopy) or guided by CT or ultrasound.

Treatment and follow-up

Neuroendocrine Cancer UK says treatment is personalised to the type of NEN and may involve removal, control of disease by slowing or stopping growth, or easing of symptoms. Appendiceal NENs of less than 1cm that are completely removed by surgery often do not need any further treatment or follow-up and are essentially cured. If the tumour is larger, shows evidence of spread, is found at the base of the appendix or the appendix has burst, further follow-up or treatment may be needed. Its follow-up guidance mentions that evidence of further disease such as enlarged nearby lymph nodes leads to a recommendation for a right hemicolectomy and lymph node assessment.

For PMP, Macmillan says the main treatments are surgery and heated chemotherapy given directly into the peritoneum (HIPEC). Cytoreductive surgery aims to remove as much of the PMP as possible, followed by the heated chemotherapy. Macmillan says this is done at two UK centres, Basingstoke and North Hampshire Hospital and the Christie Hospital in Manchester. If PMP is small or growing slowly, watchful waiting may be used and treatment may not start straight away, with regular scans and check-ups.

Cancer Research UK says treatment depends on where the cancer is and your general health. Whatever the type, the plan is made by a specialist team, and Neuroendocrine Cancer UK stresses that your care team should explain options with written and verbal information so you can make an informed choice.

NHS and private care in general terms

In the UK, appendix tumours are usually identified through NHS surgery and pathology, and rarer or more complex cases are discussed by specialist multidisciplinary teams, sometimes at a regional or national centre. Macmillan notes that you may need to travel to a specialist centre for PMP surgery.

Some people seek a private second opinion on pathology or the treatment plan. It is reasonable to ask your surgeon or clinical nurse specialist for copies of your histology report and scans so that any second opinion is based on the same information.

Frequently asked

Questions people ask.

Quick, plain-English answers to the questions we hear most.

  • How common is appendiceal cancer?

    Neuroendocrine Cancer UK describes appendix tumours as uncommon, and Cancer Research UK describes pseudomyxoma peritonei as very rare. The sources read do not give exact national figures.

  • Why was it found after my appendix operation?

    Neuroendocrine Cancer UK says appendix tumours are usually found only after treatment, when the removed appendix is examined under the microscope. The symptoms often look like appendicitis, so the operation is done for that reason.

  • Do I need more surgery after the appendix has been removed?

    It depends. Neuroendocrine Cancer UK says small tumours under 1cm that are completely removed often need no further treatment, while larger tumours, tumours at the base, spread or a burst appendix may need further follow-up or treatment.

  • What is pseudomyxoma peritonei?

    Cancer Research UK describes it as a very rare cancer that usually begins in the appendix and produces jelly-like mucin that collects in the abdomen. It grows slowly and spreads within the abdomen rather than through the blood.

  • What symptoms should I look out for?

    Symptoms may mimic appendicitis, with pain in the lower right side. For PMP, Macmillan lists a growing waist size, hernia, loss of appetite, weight gain, tummy or pelvic pain and bowel changes.

  • When is abdominal pain an emergency?

    The NHS says to call 999 or go to A&E for severe tummy pain or signs of sepsis, and to ask for an urgent GP appointment or NHS 111 for pain that is getting worse, does not go away or moves to the lower right side.

  • Is it hereditary?

    The sources read do not describe an inherited pattern for appendiceal cancer. Cancer Research UK says the cause of pseudomyxoma peritonei is not known. Raise any family history with your specialist.

  • What is the outlook?

    It varies by type and stage. Neuroendocrine Cancer UK says small completely removed tumours are essentially cured, while Cancer Research UK says PMP grows slowly. Ask your specialist team about your own case.

  • Where is PMP surgery done in the UK?

    Macmillan says cytoreductive surgery with HIPEC is done at two centres, Basingstoke and North Hampshire Hospital and the Christie Hospital in Manchester, so you may be referred to a specialist centre.

  • Will I need follow-up scans?

    Possibly. Neuroendocrine Cancer UK describes follow-up as tailored to you, from none after small completely removed tumours to regular CT scans for larger ones. Macmillan says PMP is monitored with scans, blood tests and check-ups.

Where this comes from

Sources and checking.

This guide is for information, not medical advice.

Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.

Published 2026-10-10, next review 2027-10-10.